In the previous trading session, investors closely tracked quarterly earnings, regulatory updates, strategic partnerships and corporate actions across various sectors.
Market participants are expected to remain focused on company-specific developments, including financial performance, regulatory clearances, product approvals, shareholder decisions and fresh listings that could influence stock movement during today’s trading session.
PhysicsWallah reported a significant improvement in its financial performance for the fourth quarter. The company’s consolidated loss narrowed to ₹74.9 crore from a loss of ₹293.1 crore in the corresponding period last year, while revenue surged 50.7% to ₹918.8 crore from ₹609.6 crore, reflecting strong growth in its education business.
Ashok Leyland posted a strong set of quarterly numbers. Consolidated net profit increased 14.2% year-on-year to ₹1,290.7 crore from ₹1,130.1 crore, while revenue rose 17.4% to ₹17,246.4 crore from ₹14,695.6 crore. The results highlight continued resilience in the commercial vehicle segment.
GMR Airports returned to profitability during the quarter, reporting a consolidated profit of ₹302.4 crore compared with a loss of ₹237.6 crore a year earlier. Revenue jumped 37.5% to ₹3,938.2 crore from ₹2,863.3 crore, supported by robust passenger traffic and airport operations.
PG Electroplast reported mixed quarterly results. Consolidated profit declined 55.3% year-on-year to ₹64.9 crore from ₹145.2 crore, while revenue fell 10.1% to ₹1,716.7 crore from ₹1,909.9 crore. Investors will assess the implications of the weaker earnings performance.
Swiggy’s proposed amendment to its Articles of Association received 72.36% shareholder approval, falling short of the 75% threshold required for a special resolution. The amendment was intended to support the company’s objective of qualifying as an Indian Owned and Controlled Company (IOCC) under applicable foreign exchange regulations.
Lupin received the Establishment Inspection Report (EIR) from the US Food and Drug Administration for its Ankleshwar manufacturing facility in Gujarat. The report follows the successful closure of a product-specific pre-approval inspection conducted earlier this year and is expected to support the company’s regulatory standing in the US market.
Wockhardt received approval from the Central Drugs Standard Control Organisation (CDSCO) for the import and marketing of Zaynich (Zidebactam/Cefepime) in India. The antibiotic has been approved for the treatment of complicated urinary tract infections, including pyelonephritis and associated Gram-negative bacterial infections in adults.
Q-Line Biotech is scheduled to make its market debut today as part of the SME segment listings. Investors will closely monitor the stock’s performance following its listing and initial market response.
RITES signed a Memorandum of Understanding with CRISIL to combine infrastructure consultancy expertise with data intelligence, analytics and market research capabilities. The partnership aims to deliver integrated and data-driven infrastructure solutions.
Tata Elxsi launched AnaTel, an AI-native software development platform for healthcare and medical technology companies. The platform has been co-developed with OpenAna and is designed to accelerate software engineering through autonomous AI capabilities.
Reliance Industries announced that its 49th Annual General Meeting will be held on June 19. Investors will watch for strategic updates, business expansion plans and management commentary during the event.
The Government of India has exercised the oversubscription option in Coal India’s offer-for-sale. The total offer size has been increased to 12.32 crore shares, representing a 2% stake in the company, compared with the initial offer size of 6.16 crore shares.
Indoco Remedies received EU GMP certification from the German Health Authority for its Oral Solid Dosage manufacturing facility in Baddi, Himachal Pradesh. The certification strengthens the company’s regulatory compliance credentials in European markets.
West Coast Paper Mills will remain in focus as investors track developments around its business operations and sectoral trends amid broader activity in paper and packaging stocks.
Quarterly earnings, regulatory approvals, shareholder developments, healthcare product authorisations and strategic partnerships are expected to drive stock-specific action in today’s trading session. Investors are likely to monitor these developments closely for cues on near-term market direction.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: May 29, 2026, 8:52 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN